CN101721610B - Medicine for treating tumors - Google Patents
Medicine for treating tumors Download PDFInfo
- Publication number
- CN101721610B CN101721610B CN2008101578507A CN200810157850A CN101721610B CN 101721610 B CN101721610 B CN 101721610B CN 2008101578507 A CN2008101578507 A CN 2008101578507A CN 200810157850 A CN200810157850 A CN 200810157850A CN 101721610 B CN101721610 B CN 101721610B
- Authority
- CN
- China
- Prior art keywords
- weight portions
- medicine
- radix
- tumors
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides a medicine for treating tumors, which is prepared from paris polyphylla, radix aconiti, radix aconiti praeparata, oldenlandia diffusa, dandelion, honeysuckle, centipede, tianlong, ginseng, ganoderma lucidum, astragalus root, coptis root, angelica and the like according to proportioning. As far as the medicine for treating the tumors is concerned, the synthetic action of each medicine can be utilized to treat the tumors, the physical sign can be improved, the autoimmunity can be enhanced, the curative effect is good, application is convenient, no toxic or side effect exists and treatment cost is low; clinically used by 300 patients, the medicine enjoys a total effective rate of 90% and can be mainly used for treating the tumors of the digestive system and the pulmonary tumors,.
Description
Technical field
The invention provides a kind of medicine, especially a kind of medicine of treating tumor.
Background technology
Tumor (being malignant tumor) is the healthy a kind of disease of serious harm human life, and mortality rate is high.Along with the influence of the various factorss such as continuous increase of a large amount of uses of the aggravation of environmental pollution, pesticide, mental pressure, the sickness rate of tumor obviously increases, and the trend of rejuvenation occurs.All the time, the conventional treatments of tumor is exactly operation, radiotherapy, chemotherapy etc.These methods are just controlled table, can not fundamentally thoroughly treat.And the expense of great number and serious misery can make many patient's abandoning cure.
Summary of the invention
Technical problem to be solved by this invention is a kind of medicine of treating tumor to be provided, to improve its therapeutic effect.
The present invention is achieved in that a kind of medicine of treating tumor, and it is processed by following raw materials by weight proportions:
Rhizoma Paridis 20-30 weight portions
Radix Aconiti 15-30 weight portions
Radix Aconiti Lateralis Preparata 15-30 weight portions
Herba Hedyotidis Diffusae 20-50 weight portions
Herba Taraxaci 20-50 weight portions
Flos Lonicerae 15-30 weight portions
Scolopendra 5-10 weight portions
Gekko Swinhonis 10-20 weight portions
Radix Ginseng 15-30 weight portions
Ganoderma 10-20 weight portions
The Radix Astragali 30-60 weight portions
Rhizoma Coptidis 15-30 weight portions
Radix Angelicae Sinensis 15-30 weight portions
Rhizoma Polygonati 15-30 weight portions
The Radix Aucklandiae 15-30 weight portions
Radix Glycyrrhizae 10-30 weight portions.
The medicine of this treatment tumor, comprehensive function of respectively distinguishing the flavor of medicine capable of using is treated tumor, improves sign; Improve autoimmunity, therapeutic effect is good, and clinical 300 routine patients use; Total effective rate 90%, and medication is convenient, has no side effect; Medical expense is low, can be mainly used in the treatment of digestive system tumor and lung tumors.
The specific embodiment
Further specify the present invention below.
Gekko Swinhonis is claimed Gekko Swinhonis again.
Each flavor medicine is mixed the back decocting, and the decocting method is identical with existing conventional decocting method, behind twice of the decocting, twice gained medicinal liquid is mixed, and heats to be concentrated into 550-650 milliliters.In medicinal liquid, add 1700-1900 milliliters of mass percents again and be 95% ethanol, fully stir the back and placed 23-25 hours, filter then, reclaim ethanol again or heat the ethanol volatilization is totally got final product through water proof.
When taking, get 80-130 milliliters of medicinal liquids heat back or direct oral taking.Every day 2-3 times, 30 days was 1 course of treatment.
General medication is after 15-30 days, and invalid diet, sleep, pain are obviously improved.2-3 the course of treatment posterior tuberosity body dwindling in various degree arranged, 3-6 the course of treatment posterior tuberosity body obviously dwindle or disappear, after 6 courses of treatment were above, part patient can reach clinical cure.
The criterion of curative effect: clinical cure, after treatment, healthy survival is more than 5 years.Produce effects, after treatment, healthy survival is more than 2 years.Effectively, after treatment, pain, diet, sleep quality obviously improve.Invalid, after treatment, symptom does not have obvious improvement or increases the weight of.Total effective rate: clinical cure rate+obvious effective rate+effective percentage.
With the present invention's Drug therapy middle and advanced stage tumor patient 300 examples, recurrence after operation 100 examples are wherein accepted the undesirable patient that maybe can not continue to treat 102 examples after the chemotherapy, be diagnosed as tumor but do not pass through other treatment patient's 98 examples.Above case is digestive system tumor or lung tumors.After employing the present invention's medicine was treated, clinical cure rate was 35%, and obvious effective rate is 45%, and effective percentage is 10%, and total effective rate is 90%.
Tumor is caused by reasons such as qi stagnation blood stasis, diseases caused by exogenous pathogenic factor ailment said due to cold or exposure, tobacco and wine are excessive, diet is harmful, environmental pollutions, also be comprehensively to the destruction of human body, and treatment also should be carried out comprehensively.In the present invention's the medicine, YIZHIHUA, Herba Hedyotidis Diffusae, Herba Taraxaci, Flos Lonicerae in seven, heat-clearing and toxic substances removing, reducing swelling and alleviating pain.Dispel the wind eliminating impediment, warming the spleen and stomach, YANG invigorating of Radix Aconiti, Radix Aconiti Lateralis Preparata is empty.Radix Astragali tonify deficiency QI invigorating, by stagnant blood, evacuation of pus pain relieving.Radix Ginseng tonifying five ZANG-organs six internal organs, calm the nerves, promoting blood circulation, broken hard.The Rhizoma Coptidis clearing away heat-fire.Radix Angelicae Sinensis blood circulation promoting and enriching, pain relieving, evacuation of pus.The Rhizoma Polygonati invigorating the spleen and replenishing QI, remove rheumatism, settling five organs, replenishing essence marrow.Ganoderma tranquillizing and allaying excitement, relieving cough and asthma.Radix Aucklandiae sterilization exorcises evil spirits gas, blending at gas.Scolopendra, Gekko Swinhonis expelling wind for relieving convulsion, powder detoxifcation.Radix Glycyrrhizae tonify deficiency QI invigorating, heat-clearing and toxic substances removing, eliminating phlegm and stopping cough, coordinating the actions of various ingredients in a prescription.Be monarch drug with the Rhizoma Paridis in the side, poisonous, this medicine self does not have obvious inhibitory action to tumor, needs other drug rationally to cooperate, and it mainly contains effective constituent and is wherein paridin and aminoacid.The Radix Astragali, Radix Ginseng, Radix Aconiti, Radix Aconiti Lateralis Preparata are ministerial drug, and Radix Aconiti, Radix Aconiti Lateralis Preparata are big poison, and directly acting to tumor is wherein aconitine, and the traditional Chinese medical science is thought treating the poisonous disease with poisonous drugs, is the worrior; Radix Ginseng, the Radix Astragali are tonic; The vigour of tonifying five ZANG-organs six internal organs improves body immunity, stops the cancerous cell development; Be the civil official; Main effective ingredient is ginsenoside, triterpenoid saponin, choline, betanin, polysaccharide etc., and Herba Hedyotidis Diffusae, Herba Taraxaci, Flos Lonicerae, Radix Angelicae Sinensis, Ganoderma, Rhizoma Coptidis, Rhizoma Polygonati are adjuvant drug, and its main effective ingredient has chlorogenic acid, isochlorogenic acid, taraxol, choline, butylidenephthalide, organic acid, polysaccharide, berberine, coptisine etc.; Have effects such as heat-clearing and toxic substances removing, activating blood circulation to dissipate blood stasis, reducing swelling and alleviating pain, in oncotherapy, play important effect.Scolopendra, Gekko Swinhonis, the Radix Aucklandiae are messenger drug; Lead the through sick institute of all medicines; And assist all medicine kill cancer cells, its main effective ingredient has cholesterol, formic acid, aristolone, debilic acid, magnoflorine etc., and many ingredients of Gekko Swinhonis can direct kill cancer cell.The main effect of Radix Glycyrrhizae is a coordinating the actions of various ingredients in a prescription, dissolves the toxicity of toxic medicament, and main effective ingredient has glycyrrhizin, isoliquiritigenin, liquiritin etc.Perfect square has heat-clearing and toxic substances removing, activating blood circulation to dissipate blood stasis, reducing swelling and alleviating pain, effects such as broken hard removing food stagnancy, and the reasonable adapted of every medicine can reach the purpose of treatment tumor.
Embodiment 1
Take by weighing Rhizoma Paridis 20g, Radix Aconiti 15g, Radix Aconiti Lateralis Preparata 15g, Herba Hedyotidis Diffusae 20g, Herba Taraxaci 20g, Flos Lonicerae 15g, Scolopendra 5g, Gekko Swinhonis 10g, Radix Ginseng 15g, Ganoderma 10g, Radix Astragali 30g, Rhizoma Coptidis 15g, Radix Angelicae Sinensis 15g, Rhizoma Polygonati 15g, Radix Aucklandiae 15g, Radix Glycyrrhizae 10g.Each flavor medicine is mixed the back decocting, and the decocting method is identical with existing conventional decocting method, behind twice of the decocting, twice gained medicinal liquid is mixed, and heats to be concentrated into 550 milliliters.In medicinal liquid, add 1700 milliliters of mass percents again and be 95% ethanol, fully stir the back and placed 23 hours, filter then, heating through water proof more totally gets final product the ethanol volatilization.
Embodiment 2
Take by weighing Rhizoma Paridis 30g, Radix Aconiti 30g, Radix Aconiti Lateralis Preparata 30g, Herba Hedyotidis Diffusae 50g, Herba Taraxaci 50g, Flos Lonicerae 30g, Scolopendra 10g, Gekko Swinhonis 20g, Radix Ginseng 30g, Ganoderma 20g, Radix Astragali 60g, Rhizoma Coptidis 30g, Radix Angelicae Sinensis 30g, Rhizoma Polygonati 30g, Radix Aucklandiae 30g, Radix Glycyrrhizae 30g.Each flavor medicine is mixed the back decocting, and the decocting method is identical with existing conventional decocting method, behind twice of the decocting, twice gained medicinal liquid is mixed, and heats to be concentrated into 650 milliliters.In medicinal liquid, add 1900 milliliters of mass percents again and be 95% ethanol, fully stir the back and placed 25 hours, filter then, heating through water proof more totally gets final product the ethanol volatilization.
Embodiment 3
Take by weighing Rhizoma Paridis 25g, Radix Aconiti 20g, Radix Aconiti Lateralis Preparata 20g, Herba Hedyotidis Diffusae 35g, Herba Taraxaci 35g, Flos Lonicerae 20g, Scolopendra 8g, Gekko Swinhonis 15g, Radix Ginseng 20g, Ganoderma 15g, Radix Astragali 45g, Rhizoma Coptidis 20g, Radix Angelicae Sinensis 20g, Rhizoma Polygonati 20g, Radix Aucklandiae 25g, Radix Glycyrrhizae 20g.Each flavor medicine is mixed the back decocting, and the decocting method is identical with existing conventional decocting method, behind twice of the decocting, twice gained medicinal liquid is mixed, and heats to be concentrated into 600 milliliters.In medicinal liquid, add 1800 milliliters of mass percents again and be 95% ethanol, fully stir the back and placed 24 hours, filter then, heating through water proof more totally gets final product the ethanol volatilization.
Claims (1)
1. medicine of treating tumor is characterized in that it is processed by following raw materials by weight proportions:
Rhizoma Paridis 20-30 weight portions
Radix Aconiti 15-30 weight portions
Radix Aconiti Lateralis Preparata 15-30 weight portions
Herba Hedyotidis Diffusae 20-50 weight portions
Herba Taraxaci 20-50 weight portions
Flos Lonicerae 15-30 weight portions
Scolopendra 5-10 weight portions
Gekko Swinhonis 10-20 weight portions
Radix Ginseng 15-30 weight portions
Ganoderma 10-20 weight portions
The Radix Astragali 30-60 weight portions
Rhizoma Coptidis 15-30 weight portions
Radix Angelicae Sinensis 15-30 weight portions
Rhizoma Polygonati 15-30 weight portions
The Radix Aucklandiae 15-30 weight portions
Radix Glycyrrhizae 10-30 weight portions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101578507A CN101721610B (en) | 2008-10-15 | 2008-10-15 | Medicine for treating tumors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101578507A CN101721610B (en) | 2008-10-15 | 2008-10-15 | Medicine for treating tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101721610A CN101721610A (en) | 2010-06-09 |
| CN101721610B true CN101721610B (en) | 2012-06-06 |
Family
ID=42443560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101578507A Expired - Fee Related CN101721610B (en) | 2008-10-15 | 2008-10-15 | Medicine for treating tumors |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101721610B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108853355A (en) * | 2018-08-09 | 2018-11-23 | 黔西南州长霖种植农民专业合作社 | A kind of antitumor radix tetrastigme Chinese materia medica preparation and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101028418A (en) * | 2007-04-10 | 2007-09-05 | 王济民 | Medicine for tumor |
-
2008
- 2008-10-15 CN CN2008101578507A patent/CN101721610B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101028418A (en) * | 2007-04-10 | 2007-09-05 | 王济民 | Medicine for tumor |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101721610A (en) | 2010-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
| CN102961648B (en) | Traditional Chinese medicine compound preparation for treating advanced colorectal cancer | |
| CN103768523A (en) | Chinese herbal medicine compound preparation for treating malignant tumors and preparation method of compound preparation | |
| CN103127422B (en) | Medicament for treating ulcerative colitis | |
| CN104288496A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN103272159B (en) | Chinese herbal preparation used for treating consumptive disease and preparation method thereof | |
| CN104771652A (en) | Vertigo treating traditional Chinese medicine composition | |
| CN112741890B (en) | Traditional Chinese medicine composition for treating vertigo and preparation method thereof | |
| CN101721610B (en) | Medicine for treating tumors | |
| CN103550548B (en) | A kind of Chinese medicine composition for the treatment of constipation | |
| CN102614466B (en) | Traditional Chinese medical preparation for treatment of lung adenocarcinoma | |
| CN101940699B (en) | Traditional Chinese medicine for assisting in treating liver cancer | |
| CN110934974A (en) | Traditional Chinese medicine composition for treating lung cancer, traditional Chinese medicine preparation and preparation method thereof | |
| CN104758652A (en) | Traditional Chinese medicine composition for treating dizziness | |
| CN102247551A (en) | Medicament for treating constipation | |
| CN103028063B (en) | Traditional Chinese medicine composition for treating nephropathy | |
| WO2011147231A1 (en) | Medicinal composition for treating leukemia, preparing method and use thereof | |
| CN101985027A (en) | Chinese herbal medicine for treating liver cirrhosis | |
| CN101433627A (en) | Chinese medicine prescription for treating children's lymphonodi mesosteniales inflammation | |
| CN101224295A (en) | Chinese traditional medicine compounds for treating digestive system tumor and preparing method thereof | |
| CN105079580A (en) | Traditional Chinese medicine composition for treating wind-warm lung-heat disease | |
| CN105250746A (en) | Heat clearing and toxin removing oral liquid and preparation method thereof | |
| CN104435950A (en) | Traditional Chinese medicinal styptic powder for treating upper gastrointestinal hemorrhage and preparation method thereof | |
| CN104491823A (en) | Traditional Chinese medicine electuary for treating dysmenorrheal and preparation method of traditional Chinese medicine electuary |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120606 Termination date: 20141015 |
|
| EXPY | Termination of patent right or utility model |